Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes
Our objective was to determine if the resistance mechanism to moxidectin (MOX) is similar of that to ivermectin (IVM) and involves P-glycoproteins (PGPs). Several Caenorhabditis elegans strains were used: an IVM and MOX sensitive strain, 13 PGP deletion strains and the IVM-R strain which shows synt...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-12-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221132071400013X |
id |
doaj-3a951bf00f8e48fb95b104c83234c870 |
---|---|
record_format |
Article |
spelling |
doaj-3a951bf00f8e48fb95b104c83234c8702020-11-24T22:48:56ZengElsevierInternational Journal for Parasitology: Drugs and Drug Resistance2211-32072014-12-014314315110.1016/j.ijpddr.2014.06.002Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodesElizabeth E. Bygarski0Roger K. Prichard1Bernadette F. Ardelli2Department of Biology, Brandon University, 270-18th Street, Brandon, Manitoba R7A 6A9, CanadaInstitute of Parasitology, McGill University, 21-111 Lakeshore Road, Ste-Anne-de-Bellevue, Quebec H9X 3V9, CanadaDepartment of Biology, Brandon University, 270-18th Street, Brandon, Manitoba R7A 6A9, Canada Our objective was to determine if the resistance mechanism to moxidectin (MOX) is similar of that to ivermectin (IVM) and involves P-glycoproteins (PGPs). Several Caenorhabditis elegans strains were used: an IVM and MOX sensitive strain, 13 PGP deletion strains and the IVM-R strain which shows synthetic resistance to IVM (by creation of three point mutations in genes coding for α-subunits of glutamate gated chloride channels [GluCls]) and cross-resistance to MOX. These strains were used to compare expression of PGP genes, measure motility and pharyngeal pumping phenotypes and evaluate the ability of compounds that inhibit PGP function to potentiate sensitivity or reverse resistance to MOX. The results suggest that C. elegans may use regulation of PGPs as a response mechanism to MOX. This was indicated by the over-expression of several PGPs in both drug sensitive and IVM-R strains and the significant changes in phenotype in the IVM-R strain in the presence of PGP inhibitors. However, as the inhibitors did not completely disrupt expression of the phenotypic traits in the IVM-R strain, this suggests that there likely are multiple avenues for MOX action that may include receptors other than GluCls. If MOX resistance was mediated solely by GluCls then exposure of the IVM-R strain to PGP inhibitors should not have affected sensitivity to MOX. Targeted gene deletions showed that protection of C. elegans against MOX involves complex mechanisms and depends on the PGP gene family, particularly PGP-6. While the results presented are similar to others using IVM, there were some important differences observed with respect to PGPs which may play a role in the disparities seen in the characteristics of resistance to IVM and MOX. The similarities are of concern as parasites resistant to IVM show some degree but not complete cross-resistance to MOX; this could impact nematodes that are resistant to IVM. http://www.sciencedirect.com/science/article/pii/S221132071400013XCaenorhabditisMoxidectinABC systemsP-glycoproteinInhibitionMotilityPharyngeal pumping |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elizabeth E. Bygarski Roger K. Prichard Bernadette F. Ardelli |
spellingShingle |
Elizabeth E. Bygarski Roger K. Prichard Bernadette F. Ardelli Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes International Journal for Parasitology: Drugs and Drug Resistance Caenorhabditis Moxidectin ABC systems P-glycoprotein Inhibition Motility Pharyngeal pumping |
author_facet |
Elizabeth E. Bygarski Roger K. Prichard Bernadette F. Ardelli |
author_sort |
Elizabeth E. Bygarski |
title |
Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes |
title_short |
Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes |
title_full |
Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes |
title_fullStr |
Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes |
title_full_unstemmed |
Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes |
title_sort |
resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter p-glycoproteins: implications for control of drug resistant parasitic nematodes |
publisher |
Elsevier |
series |
International Journal for Parasitology: Drugs and Drug Resistance |
issn |
2211-3207 |
publishDate |
2014-12-01 |
description |
Our objective was to determine if the resistance mechanism to moxidectin (MOX) is similar of that to ivermectin (IVM) and involves P-glycoproteins (PGPs). Several Caenorhabditis elegans strains were used: an IVM and MOX sensitive strain, 13 PGP deletion strains and the IVM-R strain which shows synthetic resistance to IVM (by creation of three point mutations in genes coding for α-subunits of glutamate gated chloride channels [GluCls]) and cross-resistance to MOX. These strains were used to compare expression of PGP genes, measure motility and pharyngeal pumping phenotypes and evaluate the ability of compounds that inhibit PGP function to potentiate sensitivity or reverse resistance to MOX. The results suggest that C. elegans may use regulation of PGPs as a response mechanism to MOX. This was indicated by the over-expression of several PGPs in both drug sensitive and IVM-R strains and the significant changes in phenotype in the IVM-R strain in the presence of PGP inhibitors. However, as the inhibitors did not completely disrupt expression of the phenotypic traits in the IVM-R strain, this suggests that there likely are multiple avenues for MOX action that may include receptors other than GluCls. If MOX resistance was mediated solely by GluCls then exposure of the IVM-R strain to PGP inhibitors should not have affected sensitivity to MOX. Targeted gene deletions showed that protection of C. elegans against MOX involves complex mechanisms and depends on the PGP gene family, particularly PGP-6. While the results presented are similar to others using IVM, there were some important differences observed with respect to PGPs which may play a role in the disparities seen in the characteristics of resistance to IVM and MOX. The similarities are of concern as parasites resistant to IVM show some degree but not complete cross-resistance to MOX; this could impact nematodes that are resistant to IVM.
|
topic |
Caenorhabditis Moxidectin ABC systems P-glycoprotein Inhibition Motility Pharyngeal pumping |
url |
http://www.sciencedirect.com/science/article/pii/S221132071400013X |
work_keys_str_mv |
AT elizabethebygarski resistancetothemacrocycliclactonemoxidectinismediatedinpartbymembranetransporterpglycoproteinsimplicationsforcontrolofdrugresistantparasiticnematodes AT rogerkprichard resistancetothemacrocycliclactonemoxidectinismediatedinpartbymembranetransporterpglycoproteinsimplicationsforcontrolofdrugresistantparasiticnematodes AT bernadettefardelli resistancetothemacrocycliclactonemoxidectinismediatedinpartbymembranetransporterpglycoproteinsimplicationsforcontrolofdrugresistantparasiticnematodes |
_version_ |
1725677949145841664 |